| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75913SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12023-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35070-10ug | |||
| Carrier-Free | NBP2-35070-1mg | |||
| Carrier-Free | NBP2-35070-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12011-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12022-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26203-50ul | |||
![ELISA: Human QSOX1/Quiescin Q6 ELISA Kit (Colorimetric) [NBP3-40300] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-40300_human-qsox1-quiescin-q6-elisa-kit-colorimetric-2110202415264360.png "ELISA: Human QSOX1/Quiescin Q6 ELISA Kit (Colorimetric) [NBP3-40300] - Standard Curve Reference")
![ELISA: Human SHC1 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-40501] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-40501_human-shc1-ready-to-use-elisa-kit-colorimetric-2110202415355092.png "ELISA: Human SHC1 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-40501] - Standard Curve Reference")
![ELISA: Human MDA5 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39588] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39588_human-mda5-ready-to-use-elisa-kit-colorimetric-211020241528267.png "ELISA: Human MDA5 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39588] - Standard Curve Reference")
![ELISA: Human PA2G4/EBP1 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39463] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39463_human-pa2g4-ebp1-ready-to-use-elisa-kit-colorimetric-2110202415264312.png "ELISA: Human PA2G4/EBP1 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39463] - Standard Curve Reference")
![ELISA: Human DLL3 Â - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-31368] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-31368_human-dll3-ready-to-use-elisa-kit-colorimetric-20620241525240.png "ELISA: Human DLL3 Â - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-31368] - Standard Curve Reference")
![ELISA: Human KLF10 ELISA Kit (Colorimetric) [NBP3-40214] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-40214_human-klf10-elisa-kit-colorimetric-2110202415384014.png "ELISA: Human KLF10 ELISA Kit (Colorimetric) [NBP3-40214] - Standard Curve Reference")
![Flow Cytometry: IL-9 Antibody (RM9A4) - Chimeric [NBP3-12023] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of RM9A4 (NBP3-12023, pink line) at a dilution of 1:100 for 1h at RT. The blue line shows unstimulated human peripheral blood leukocytes stained with NBP3-12023. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-9-Antibody-RM9A4-Chimeric-Flow-Cytometry-NBP3-12023-img0001.jpg "Flow Cytometry: IL-9 Antibody (RM9A4) - Chimeric [NBP3-12023] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of RM9A4 (NBP3-12023, pink line) at a dilution of 1:100 for 1h at RT. The blue line shows unstimulated human peripheral blood leukocytes stained with NBP3-12023. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![Flow Cytometry: IL-9 Antibody (MH9A4) - Chimeric [NBP3-12022] - Human peripheral blood leukocytes were rested for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MH9A4 (NBP3-12022, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-9-Antibody-MH9A4-Chimeric-Flow-Cytometry-NBP3-12022-img0001.jpg "Flow Cytometry: IL-9 Antibody (MH9A4) - Chimeric [NBP3-12022] - Human peripheral blood leukocytes were rested for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MH9A4 (NBP3-12022, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![Flow Cytometry: IL12B Antibody (10B10) [NBP3-26203] - Overlay Peak curve showing A549 cells stained with IL12B Antibody (10B10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26203_rabbit-il12b-mab-10b10-28220241431278.jpg "Flow Cytometry: IL12B Antibody (10B10) [NBP3-26203] - Overlay Peak curve showing A549 cells stained with IL12B Antibody (10B10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")